ATE179989T1 - Peptide zur behandlung von allergien - Google Patents

Peptide zur behandlung von allergien

Info

Publication number
ATE179989T1
ATE179989T1 AT95936020T AT95936020T ATE179989T1 AT E179989 T1 ATE179989 T1 AT E179989T1 AT 95936020 T AT95936020 T AT 95936020T AT 95936020 T AT95936020 T AT 95936020T AT E179989 T1 ATE179989 T1 AT E179989T1
Authority
AT
Austria
Prior art keywords
pct
peptides
date
terminus
sec
Prior art date
Application number
AT95936020T
Other languages
English (en)
Inventor
Denis Raymond Stanworth
Ian Victor Lewin
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Application granted granted Critical
Publication of ATE179989T1 publication Critical patent/ATE179989T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95936020T 1994-11-04 1995-11-03 Peptide zur behandlung von allergien ATE179989T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9422294A GB9422294D0 (en) 1994-11-04 1994-11-04 Peptides for anti-allergy treatment

Publications (1)

Publication Number Publication Date
ATE179989T1 true ATE179989T1 (de) 1999-05-15

Family

ID=10763914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95936020T ATE179989T1 (de) 1994-11-04 1995-11-03 Peptide zur behandlung von allergien

Country Status (12)

Country Link
US (1) US5945104A (de)
EP (1) EP0789710B1 (de)
JP (1) JPH10509700A (de)
AT (1) ATE179989T1 (de)
AU (1) AU707483B2 (de)
CA (1) CA2204256A1 (de)
DE (1) DE69509673T2 (de)
DK (1) DK0789710T3 (de)
ES (1) ES2131339T3 (de)
GB (1) GB9422294D0 (de)
GR (1) GR3030777T3 (de)
WO (1) WO1996014333A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822763D0 (en) * 1998-10-20 1998-12-16 Univ Sheffield Immunoglobin variant
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000252B1 (de) * 1977-06-29 1982-02-03 Beecham Group Plc Peptiden, Verfahren zu dessen Herstellung und denen enthaltende pharmazeutische Präparate
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
EP0288965A2 (de) * 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
ES2055785T3 (es) * 1989-01-17 1994-09-01 Eniricerche Spa Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JP3329868B2 (ja) * 1992-09-30 2002-09-30 株式会社クラレ ペプチドおよびこれを担体上に固定化してなる吸着剤
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
WO1994018345A1 (en) * 1993-02-05 1994-08-18 Affymax Technologies N.V. Receptor-binding antiproliferative peptides
GB9320897D0 (en) * 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
JP3504963B2 (ja) * 1993-10-22 2004-03-08 智靖 羅 抗ヒト高親和性ＩｇＥ受容体モノクローナル抗体に係るアミノ酸配列をコードするＤＮＡ断片

Also Published As

Publication number Publication date
EP0789710A1 (de) 1997-08-20
DK0789710T3 (da) 1999-11-01
DE69509673T2 (de) 2000-01-13
DE69509673D1 (de) 1999-06-17
AU3811195A (en) 1996-05-31
ES2131339T3 (es) 1999-07-16
AU707483B2 (en) 1999-07-08
JPH10509700A (ja) 1998-09-22
GR3030777T3 (en) 1999-11-30
EP0789710B1 (de) 1999-05-12
CA2204256A1 (en) 1996-05-17
WO1996014333A1 (en) 1996-05-17
US5945104A (en) 1999-08-31
GB9422294D0 (en) 1994-12-21

Similar Documents

Publication Publication Date Title
ATE346934T1 (de) Modifizierte pflanzenviren als vektore für heterologe peptide
EP0693928A4 (de) Aminozucker- und glykosaminoglykanzusammensetzung zur behandlung und reparatus von bindegewebe
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
ATE230417T1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
DE69518760D1 (de) Wachstumsdifferenzierungsfaktor-12
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
ATE290315T1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
ATE374618T1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
DE69633393D1 (de) Mitteln zur behandlung von auto-immun krankheiten
ATE215830T1 (de) Verfahren zur detektion und behandlung von individuen mit abnormal hla-a2/tyrosinase- peptidantigenen exprimierenden zellen
EP0960117A4 (de) ZU FIBROBLASTEN-WACHSTUMSFAKTOR HOMOLOGE FAKTOREN (FHFs) UND VERFAHREN DER ANWENDUNG
ATE179989T1 (de) Peptide zur behandlung von allergien
EP0561877A4 (de)
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
MX9606674A (es) Tratamiento de enfermedades humanas que involucran la desregulacion o disfuncion del sistema nervioso.
NZ331771A (en) Lytic peptides with amphipathic alpha helices and positively charged N- or C-terminal, methods of activation/inactivation, compositions and methods of treatment are also included
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DK1438329T3 (da) Biologisk aktive peptider og deres anvendelse til reparation af beskadigede nerver
ATE234358T1 (de) Peptide des pferdearteritisvirus, antikörper und ihre verwendung in einem diagnostischen test

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee